Interpace Biosciences (IDXG) EBITDA
Market Cap: $8.83M
Avg Volume: 7.93K
Industry: Medical - Diagnostics & Research
Sector: Healthcare
What is Interpace Biosciences's EBITDA?
- Interpace Biosciences's annual EBITDA is $3.84M.
- Interpace Biosciences's quarterly EBITDA is $2.44M.
What is EBITDA?
EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances.
How is EBITDA calculated?
EBITDA is calculated using the following formula:
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
Related Metrics
Other important metrics to assess Interpace Biosciences's financial health include:
- EBITDA Ratio - measures the company's EBITDA as a percentage of its revenue:
- Annual: 9.54%
- Quarterly: 20.30%
- Growth EBITDA - measures the annual growth rate of the company's EBITDA:
- Annual: 201.48%
- Quarterly: 136.46%
- Growth EBITDA Ratio - measures the annual growth rate of the company's EBITDA ratio:
- Annual: 180.34%
- Quarterly: 101.72%
These metrics provide insights into Interpace Biosciences's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual EBITDA
$3.84M
Quarterly EBITDA
$2.44M
Interpace Biosciences Historical EBITDA
Historical EBITDA Ratio (Annual)
Historical EBITDA Ratio (Quarterly)
Interpace Biosciences Historical EBITDA Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2023.
| Year | EBITDA | Growth EBITDA | EBITDA Ratio | Growth EBITDA Ratio |
|---|---|---|---|---|
| 2023 | $3.84M | 201.48% | 9.54% | 180.34% |
| 2022 | $-3.78M | 53.79% | -11.88% | 40.03% |
| 2021 | $-8.18M | 62.17% | -19.80% | 70.33% |
| 2020 | $-21.63M | -7.68% | -66.75% | 19.97% |
| 2019 | $-20.09M | -183.61% | -83.41% | -157.89% |
| 2018 | $-7.08M | 34.24% | -32.34% | 52.26% |
| 2017 | $-10.77M | 3.45% | -67.75% | 20.53% |
| 2016 | $-11.15M | 56.97% | -85.25% | 68.98% |
| 2015 | $-25.93M | -186.12% | -274.86% | -3538.19% |
| 2014 | $-9.06M | -217.71% | -7.55% | -299.58% |